Clinical trials
Phase 2 Pathologic Complete Response trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Unknown status | 9 |
| Completed | 8 |
| Not yet recruiting | 7 |
| Withdrawn | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Henan Cancer Hospital | 3 |
| Fudan University | 2 |
| Peking University People's Hospital | 2 |
| Tang-Du Hospital | 2 |
| Anhui Provincial Hospital | 1 |
| Armando Giuliano | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Barwon Health | 1 |
| Beijing Friendship Hospital | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 41 |
| Breast Neoplasms | 16 |
| Leukemia, Myeloid, Acute | 5 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Head and Neck Neoplasms | 3 |
| Rectal Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasm, Residual | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.